Evidence map›Paper›PMID 23378299›Full record

Trial reportCirculation2013

Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.

Anjali Ganda, Martin Magnusson, Laurent Yvan-Charvet, Bo Hedblad, Gunnar Engström, Ding Ai, Thomas J Wang, Robert E Gerszten, Olle Melander, Alan R Tall

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Circulation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Lipid profiles and their potential inflammatory effects in anti-N-methyl-D-aspartate receptor encephalitis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. The effect of chronic kidney disease on lipid metabolism.International urology and nephrology · 2019
    Review
  19. Lipid management in patients with chronic kidney disease.Nature reviews. Nephrology · 2018 · on this map
    Review
  20. Macrophages and lipid metabolism.Cellular immunology · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anjali GandaDivision of Nephrology, College of Physicians & Surgeons, Columbia University, PH4-124, 622 W 168th St, New York, NY 10032, USA. ag355@columbia.edu
Martin Magnusson
Laurent Yvan-Charvet
Bo Hedblad
Gunnar Engström
Ding Ai
Thomas J Wang
Robert E Gerszten
Olle Melander
Alan R Tall
Massachusetts General Hospital · USHarvard University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Metabolomic predictors of insulin resistance and diabetesR01DK081572 · NIDDK · VANDERBILT UNIVERSITY · PI CLISH, CLARY B, GERSZTEN, ROBERT E · 2008 to 2025
$9.3M
Metabolomic Biomarkers of Early Myocardial InjuryR01HL098280 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI GERSZTEN, ROBERT E, SABATINE, MARC S · 2010 to 2014
$3.7M
Clinical Evaluation of Novel Markers of MIR01HL072872 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI GERSZTEN, ROBERT E · 2002 to 2005
$1.5M
NCATS NIH HHS UL1 TR000040NCRR NIH HHS UL1 RR024156NHLBI NIH HHS HL 98280NHLBI NIH HHS R01 HL072872NHLBI NIH HHS R01 HL098280NIDDK NIH HHS DK 081572NIDDK NIH HHS R01 DK081572
6 · The paper itself

Abstract

backgroundThe number of circulating blood monocytes impacts atherosclerotic lesion size, and in mouse models, elevated levels of high-density lipoprotein cholesterol suppress blood monocyte counts and atherosclerosis. We hypothesized that individuals with mild renal dysfunction at increased cardiovascular risk would have reduced high-density lipoprotein levels, high blood monocyte counts, and accelerated atherosclerosis. METHODS AND

resultsTo test whether mild renal dysfunction is associated with an increase in a leukocyte subpopulation rich in monocytes that has a known association with future coronary events, we divided individuals from the Malmö Diet and Cancer study (MDC) into baseline cystatin C quintiles (n=4757). Lower levels of renal function were accompanied by higher monocyte counts, and monocytes were independently associated with carotid bulb intima-media thickness cross-sectionally (P=0.02). Cystatin C levels were positively and plasma high-density lipoprotein cholesterol levels negatively associated with monocyte counts at baseline, after adjustment for traditional risk factors. Several amino acid metabolites tied to low levels of high-density lipoprotein cholesterol and insulin resistance measured in a subset of individuals (n=752) by use of liquid chromatography-mass spectrometry were independently associated with a 22% to 34% increased risk of being in the top quartile of monocytes (P<0.05).

conclusionsA low high-density lipoprotein cholesterol, insulin resistance phenotype occurs in subjects with mild renal dysfunction and is associated with elevated monocytes and atherosclerosis. High blood monocyte counts may represent a previously unrecognized mechanism underlying the strong relationship between cystatin C and cardiovascular risk.

Indexed as

AgedAtherosclerosisCase-Control StudiesCholesterol, HDLCohort StudiesCross-Sectional StudiesFemaleHumansKidney DiseasesKidney Function TestsLeukocytosisMaleMiddle AgedMonocytesProspective StudiesRisk FactorsCholesterol, HDL

Identifiers

PMID23378299
PMCPMC4074592
OpenAlexW2163514388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.